Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Neurobiol Dis. 2021 Jan;148:105198. doi: 10.1016/j.nbd.2020.105198. Epub 2020 Nov 24.
Alzheimer's disease (AD) leads to cerebral accumulation of insoluble amyloid-β plaques causing synaptic dysfunction and neuronal death. Neurons rely on astrocyte-derived glutamine for replenishment of the amino acid neurotransmitter pools. Perturbations of astrocyte glutamine synthesis have been described in AD, but whether this functionally affects neuronal neurotransmitter synthesis is not known. Since the synthesis and recycling of neurotransmitter glutamate and GABA are intimately coupled to cellular metabolism, the aim of this study was to provide a functional investigation of neuronal and astrocytic energy and neurotransmitter metabolism in AD. To achieve this, we incubated acutely isolated cerebral cortical and hippocampal slices from 8-month-old female 5xFAD mice, in the presence of C isotopically enriched substrates, with subsequent gas chromatography-mass spectrometry (GC-MS) analysis. A prominent neuronal hypometabolism of [U-C]glucose was observed in the hippocampal slices of the 5xFAD mice. Investigating astrocyte metabolism, using [1,2-C]acetate, revealed a marked reduction in glutamine synthesis, which directly hampered neuronal synthesis of GABA. This was supported by an increased metabolism of exogenously supplied [U-C]glutamine, suggesting a neuronal metabolic compensation of the reduced astrocytic glutamine supply. In contrast, astrocytic metabolism of [U-C]GABA was reduced, whereas [U-C]glutamate metabolism was unaffected. Finally, astrocyte de novo synthesis of glutamate and glutamine was hampered, whereas the enzymatic capacity of glutamine synthetase for ammonia fixation was maintained. Collectively, we demonstrate that deficient astrocyte metabolism leads to reduced glutamine synthesis, directly impairing neuronal GABA synthesis in the 5xFAD brain. These findings suggest that astrocyte metabolic dysfunction may be fundamental for the imbalances of synaptic excitation and inhibition in the AD brain.
阿尔茨海默病(AD)导致脑内不可溶性淀粉样β斑块积累,从而导致突触功能障碍和神经元死亡。神经元依赖星形胶质细胞衍生的谷氨酰胺来补充氨基酸神经递质池。AD 中已描述了星形胶质细胞谷氨酰胺合成的扰动,但这是否会对神经元神经递质合成产生功能影响尚不清楚。由于神经递质谷氨酸和 GABA 的合成和再循环与细胞代谢密切相关,因此本研究的目的是对 AD 中神经元和星形胶质细胞的能量和神经递质代谢进行功能研究。为了实现这一目标,我们在存在 C 同位素富集底物的情况下,对 8 个月大的雌性 5xFAD 小鼠的急性分离大脑皮质和海马切片进行孵育,随后进行气相色谱-质谱(GC-MS)分析。在 5xFAD 小鼠的海马切片中观察到明显的神经元代谢不足[U-C]葡萄糖。使用[1,2-C]乙酸研究星形胶质细胞代谢,发现谷氨酰胺合成明显减少,直接阻碍了神经元 GABA 的合成。这得到了外源性[U-C]谷氨酰胺代谢增加的支持,表明神经元代谢对减少的星形胶质细胞谷氨酰胺供应的补偿。相比之下,星形胶质细胞[U-C]GABA 的代谢减少,而[U-C]谷氨酸的代谢不受影响。最后,星形胶质细胞谷氨酸和谷氨酰胺的从头合成受阻,而谷氨酰胺合成酶固定氨的酶活性保持。总的来说,我们证明了缺陷的星形胶质细胞代谢导致谷氨酰胺合成减少,直接损害 5xFAD 大脑中的神经元 GABA 合成。这些发现表明,星形胶质细胞代谢功能障碍可能是 AD 大脑中突触兴奋和抑制失衡的基础。
J Cereb Blood Flow Metab. 2014-3-5
Neurochem Res. 2023-4
J Cereb Blood Flow Metab. 2011-2
Neurochem Res. 2025-9-9
J Neurochem. 2025-6
Neurochem Res. 2025-4-7
J Neurochem. 2025-3